Leadership Overview
WCG has 6 executives leading key functions including strategy, technology, revenue partnerships, clinical research solutions, market intelligence, and legal operations.
Focused on accelerating medical breakthroughs, WCG delivers essential clinical trial support to biopharmaceutical companies and research institutions globally. This leadership team drives innovation to improve patient outcomes through advanced consulting and technology.
Focused on accelerating medical breakthroughs, WCG delivers essential clinical trial support to biopharmaceutical companies and research institutions globally. This leadership team drives innovation to improve patient outcomes through advanced consulting and technology.
Leadership Roles at WCG
Geoff Wise - Chief Executive Officer
Geoff Wise, the Chief Executive Officer at WCG, directs the overarching corporate strategy to enhance clinical trial efficiency for biopharmaceutical partners. Overseeing the entire research ecosystem, the Chief Executive Officer aligns internal resources with the evolving needs of contract research organizations and research institutions. This leadership role involves scaling innovative technology platforms to accelerate the development of new treatments across North American and international markets. By fostering collaboration between sponsors and sites, Geoff Wise ensures the organization maintains a competitive edge in the complex R&D landscape. The Chief Executive Officer monitors performance metrics to guarantee that all service offerings meet rigorous ethical and quality standards. Ultimately, Wise drives long-term growth by prioritizing patient-centric solutions and operational excellence, ensuring the company remains a vital partner in the global pursuit of medical advancement and improved health outcomes.
Cynthia Carter - President, MI & I
Cynthia Carter, the President, MI & I at WCG, directs the market intelligence and insights division to provide actionable data for clinical trial stakeholders. Overseeing the analysis of research trends, the President, MI & I ensures that biopharmaceutical companies receive precise guidance for study planning and site selection. This leadership role involves synthesizing complex data sets into strategic recommendations that improve trial efficiency and patient recruitment outcomes. By leveraging deep industry knowledge, Cynthia Carter supports the development of innovative consulting services that address the unique challenges of the research ecosystem. The President, MI & I collaborates with internal teams to refine service offerings based on real-time market feedback. Through the delivery of high-impact insights, Carter empowers clients to make informed decisions, ultimately accelerating the path to new treatments and enhancing the overall quality of clinical research operations.
Terri Moench - President, Clinical Research Solutions
Terri Moench, the President, Clinical Research Solutions at WCG, directs the operational delivery of comprehensive clinical trial services to sponsors and research sites. Overseeing the execution of study planning and independent ethical review, the President, Clinical Research Solutions ensures that all projects meet the highest standards of quality and efficiency. This leadership role involves managing large-scale operational teams to support the diverse needs of the biopharmaceutical industry across various geographic regions. By optimizing internal workflows and resource allocation, Terri Moench drives improvements in trial timelines and patient safety. The President, Clinical Research Solutions collaborates with other executive leaders to integrate technology and consulting expertise into every client engagement. Through a focus on operational excellence and service delivery, Moench ensures the company consistently meets the complex demands of the modern clinical research landscape.
Paul Mancinelli - Chief Technology Officer
Paul Mancinelli, the Chief Technology Officer at WCG, architects the digital infrastructure required to optimize clinical trial data insights and study planning. Managing the development of proprietary software, the Chief Technology Officer integrates advanced analytics into the research workflow to streamline complex processes for biopharmaceutical clients. This leadership role involves overseeing cybersecurity protocols and data integrity across all digital platforms to protect sensitive research information. By implementing scalable cloud solutions, Paul Mancinelli supports the rapid expansion of clinical research capabilities on a global scale. The Chief Technology Officer collaborates with cross-functional teams to ensure that technological advancements directly translate into faster, more accurate trial results. Through continuous innovation in software engineering and data management, Mancinelli secures the company's position as a leader in the digital transformation of the clinical research industry.
Tony Castillo - Director, Chief Revenue Officer Partnerships
Tony Castillo, the Director, Chief Revenue Officer Partnerships at WCG, executes strategic growth initiatives by cultivating high-value relationships with contract research organizations and biopharmaceutical sponsors. Overseeing the expansion of the partner network, the Director, Chief Revenue Officer Partnerships identifies new market opportunities to increase the adoption of clinical trial services. This leadership role involves negotiating complex agreements and aligning service delivery with the specific requirements of diverse research institutions. By driving revenue through collaborative ventures, Tony Castillo ensures the company maintains a robust pipeline of clinical projects. The Director, Chief Revenue Officer Partnerships monitors market trends to adapt outreach strategies, ensuring consistent value delivery to all stakeholders. Through proactive engagement and relationship management, Castillo strengthens the company's market presence and supports the long-term financial stability of the organization within the competitive research services sector.
Jared Zane - Chief Legal Officer & Corporate Secretary
Jared Zane, the Chief Legal Officer & Corporate Secretary at WCG, directs all legal affairs and corporate governance initiatives to ensure compliance within the highly regulated clinical research environment. Overseeing risk management and regulatory adherence, the Chief Legal Officer & Corporate Secretary protects the company's interests while facilitating smooth operations for global research partners. This leadership role involves managing complex contractual obligations and providing legal counsel on strategic business decisions. By maintaining rigorous standards for ethical review and data privacy, Jared Zane supports the integrity of the entire research ecosystem. The Chief Legal Officer & Corporate Secretary collaborates with the Board to uphold corporate governance best practices and transparency. Through proactive legal strategy and meticulous oversight, Zane mitigates operational risks, allowing the organization to focus on its mission of accelerating medical research and improving patient outcomes.

Explore Leadership Teams in Business Services
Element Materials Technology is a global testing, inspection, and certification company serving highly regulated and safety-critical industries. It provides materials testing, product qualification, calibration, certification, and related technical services to help organizations ensure their products are safe, compliant, sustainable, and ready for market. The company works across the product lifecycle, from research and development through regulatory approval and production.
Company Leadership JP
JC
RJ
Veranex is an Innovation CRO that accelerates MedTech breakthroughs by integrating device development, preclinical and clinical trials, regulatory strategy, and market access. The company offers a comprehensive range of services including design and development, clinical research, regulatory consulting, and commercialization, tailored for the medical device and in-vitro diagnostics sectors. With over 25 years of specialized knowledge, Veranex serves a diverse clientele, including global clients in cardiovascular, neurology, ophthalmology, and biopharma fields. Their mission is to transform innovative concepts into market-ready solutions that enhance patient outcomes efficiently and effectively.
Company Leadership.jpg)
JM
DD

Oak Ridge Associated Universities (ORAU) provides innovative scientific and technical solutions to advance national priorities in science, education, and health. The organization focuses on research partnerships, public health, K-12 STEM education programs, and workforce solutions, aiming to strengthen the nation's workforce and improve community health and safety. ORAU also offers training in radiation safety and health physics, epidemiology, and environmental services. Their intended clients include government entities, educational institutions, and local communities.
Company Leadership

ND
TB
The Schaefer Center for Public Policy, part of the University of Baltimore's College of Public Affairs, specializes in applied research, policy analysis, and professional development programs aimed at enhancing public service. It offers the Maryland Certified Public Manager Program and the NextGen Leaders for Public Service Internship Program, targeting local, state, federal, and nonprofit organizations. The center is dedicated to preparing future leaders and informing decision-makers through rigorous training and strategic planning. Its clients include public sector managers and supervisors from various governmental and nonprofit entities across Maryland.
Company Leadership
NK
RG
JF